01. Anaesthetics and Oxygen
1.01. General Anaesthetics
1.01.01 Intravenous
Intravenous
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
ketamine
|
Injection |
50 mg/mL
|
|
|
thiopental
|
Powder for injection |
0.5 g (as sodium)
|
|
|
thiopental
|
Powder for injection |
1 g (as sodium)
|
|
Reserved for specialist use
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
propofol
|
Injection |
10 mg/mL
|
|
1.01.02 Inhalation
Inhalation
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
halothane
|
Liquid |
100% v/v
|
|
|
nitrous oxide
|
Inhalation (medicine gas) |
N/A
|
|
|
oxygen
|
Inhalation (medicine gas) |
N/A
|
|
Reserved for specialist use
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
isoflurane
|
Inhalation |
N/A
|
|
|
sevoflurane
|
Inhalation |
N/A
|
|
1.02. Local Anaesthetics
1.03. Preoperative and Sedation Medicines for Short-Term Procedures
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
diazepam
|
Injection |
5 mg/mL
|
|
|
midazolam
|
Injection |
5 mg/mL
|
|
02. Cholinesterase Inhibitors and Muscle Relaxants (peripherally acting and skeletal)
2.01. Cholinesterase inhibitors
2.02. Muscle Relaxants
2.02.01. Depolarizing Muscle Relaxants
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
suxamethonium
|
Injection |
50 mg/mL (chloride)
|
|
2.02.02 Non-depolarizing Muscle Relaxants
Non-depolarizing Muscle Relaxants
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
pancuronium
|
Injection |
2 mg (bromuro)/mL
|
|
|
vecuronium
|
Powder for injection |
10 mg
|
|
Reserve for specialist use
2.02.03. Skeletal Muscle Relaxants
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
diazepam
|
Injection |
5 mg/mL
|
|
03. Analgesics, Antipyretics, Nonsteroidal Anti-Inflammatory Medicines (NSAIM); Medicines used in Gout, Disease Modifying Medicines used in Rheumatoid Disorders (DMARDS)
3.01. Non-opioids
3.02 Opioid Analgesics
Opioid Analgesics
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
codeine
|
Tablet |
30 mg (phosphate)
|
|
|
fentanyl
|
Injection |
0.05 mg/mL
|
|
|
morphine
|
Injection |
10 mg/ml
|
|
|
morphine
|
Oral solution |
5 mg/5 mL
|
|
|
morphine
|
Tablet (controlled release) |
30 mg
|
|
|
morphine
|
Tablet (immediate release) |
10 mg
|
|
Reserved for specialist use
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
fentanyl
|
Patch |
N/A
|
|
|
pethidine
|
Injection |
50 mg/ml
|
|
3.03. Opioid antagonists
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
naloxone
|
Injection |
0.4 mg/mL
|
|
3.04. Medicines used to treat gout
3.05 Disease Modifying Agents used in Rheumatoid Disorders (DMARDS)
Disease Modifying Agents used in Rheumatoid Disorders (DMARDS)
Reserved for specialist use
04. Antiallergics and Medicines used in Anaphylaxis
4.01. Alkylamine
4.02 Glucocorticoids
Glucocorticoids
Reserved for specialist use
05. Antidotes and Other Substances Used in Poisonings
5.01. Non-specific
5.02. Specific
06. Anticonvulsants
6.01. Barbiturates
6.02. Benzodiazepines
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
diazepam
|
Injection |
5 mg/mL
|
|
|
lorazepam
|
Injection |
1 mg/mL
|
|
6.03. Hydantoins
6.04 Other Anticonvulsants
Other Anticonvulsants
Reserved for specialist use
07. Anti-Infective Medicines
7.01. Anthelmintics
7.01.01 Intestinal Antihelmintics
Intestinal Anthelmintics
Reserved for specialist use
7.01.02. Antifilarials
7.02. Antimicrobials
7.02.01. Aminoglycosides
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
amikacin
|
Injection |
250 mg/ml
|
|
|
gentamicin
|
Injection |
40 mg/ml
|
|
|
spectinomycin
|
Powder for injection |
2 g (as hydrochloride) in vial
|
|
7.02.02. Aminopenicillins
7.02.03. Cephalosporins
7.02.03.01. First Generation
7.02.03.02. Second Generation
| Medicamento |
Forma farmacêutica |
Composição |
Observações |
|
cefuroxime
|
Powder for injection |
250 mg (as sodium salt) in vial
|
|
|
cefuroxime
|
Tablet |
250 mg
|
|
|
cefuroxime
|
Tablet |
500 mg
|
|
